Archives: Funded Research

Identification and characterization of novel targets and activators of E6AP

Validation of biomarkers for Angelman syndrome clinical trials

Defining Treatment Parameters for Angelman Syndrome

Ube3a-ATS Targeted Antisense Oligonucleotides As Therapies for Angelman Syndrome

Preclinical Validation of Behavioral, Molecular, and Electrophysiological Effects of Acamprosate in a Mouse Model of Angelman Syndrome

Movement Disorder Analysis in Angelman Syndrome

Studies to Determine How Angelman Syndrome-associated Missense Mutations Disrupt UBE3A Function

Rett Syndrome Disorders and Angelman Syndrome as Genetic Models of Autism Spectrum Disorders

Preclinical testing of a candidate Angelman syndrome therapeutic

The role of antisense RNA Ube3a-ATS in Ube3a imprinting and Angelman syndrome